US pharmaceutical firm AbbVie is reconsidering its proposed takeover of UK rival Shire following a US tax crackdown.
In a statement, the firm said its board of directors will meet next week to reconsider the $54bn takeover, proposed in July, which would have created one of the world's largest pharma groups. AbbVie said: "AbbVie's board will consider, among other things, the impact of the US Department of Treasury's proposed unilateral changes to the tax regulations announced on 22 September, 2014, including the impact to the fundamental financial benefits of the transaction." In response today, Shire released a statement in which is said its own board wanted AbbVie to continue with the takeover pla...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
